Drug Profile
Research programme: farnesyl transferase inhibitors - Schering-Plough
Alternative Names: Sch 704742Latest Information Update: 24 Aug 2009
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class Pyridines
- Mechanism of Action Farnesyltranstransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer